Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
Phase 1 cancer clinical trials are more beneficial for participants than they used to be, says Naoko Takebe, MD, PhD.
A new study identifies a potential approach to prevent mental fog, a common treatment side effect.
The new approach takes advantage of the natural process by which cells break down proteins into fragments called peptides.
Nearly 75% of people with advanced cancer experience breathing problems. Are steroids the best treatment? A new study raises concerns.
It’s important to know how aggressive a patient’s cancer is so that their treatment can be tailored.
UPDATE: On October 25, the FDA approved Tecvayli (teclistamab) to treat some people with multiple myeloma.
The approach appears to benefit people with advanced forms of the disease but whose cancer can still be treated with surgery.
Pedmark (sodium thiosulfate) is the first med approved to lower risk of hearing loss in children treated with cisplatin chemotherapy.
Two studies found a vulnerability in gliomas—a type of brain tumors—that may open the door to new treatments for this cancer.
Now patients with non-small cell lung cancer have another targeted therapy option.
New study supports U.S. guidelines for determining which people with liver cancer are eligible for a transplant.
Cancer researchers analyzed data on half a million tea drinkers. The results suggest health benefits from black tea.
Running was associated with the greatest reduction in risk of cancer deaths, according to a new study. Here are other findings.
People with advanced cancer need fewer hospital visits when they get home care from community health workers.
Chronic inflammation can promote tumor growth, and controlling it could help fight cancer.
Researchers found that shutting down the effects of the abnormal collagen made treatments for pancreatic cancer more effective.
Compared with chemotherapy alone, adding immunotherapy drug Keytruda helped triple-negative breast cancer patients live longer.
Every year, 350 children in the United States are diagnosed with rhabdomyosarcoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.